Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance

Diabetes Care. 2005 Mar;28(3):712-3. doi: 10.2337/diacare.28.3.712.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Area Under Curve
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism*
  • Body Mass Index
  • Chromium / administration & dosage
  • Chromium / pharmacology*
  • Dietary Supplements*
  • Double-Blind Method
  • Glucose Intolerance / blood*
  • Glucose Tolerance Test
  • Humans
  • Lipids / blood
  • Placebos
  • Reproducibility of Results

Substances

  • Blood Glucose
  • Lipids
  • Placebos
  • Chromium